A2 Biotherapeutics
ID: 6535624A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells
2
Funding Rounds
$151.5m
Money raised
Recent Funding Rounds
Overview
A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells
- Website:
- Business model: B2B
- Headquarters: Agoura Hills, California
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Al******* Ka** |
|
- | - |
Funding series
Funding Series Analysis
The company A2 Biotherapeutics has raised a total of $80m in funding over 2 rounds.
Key Insights:
- A2 Biotherapeutics January 2025 Series C Funding Round: $80m
- A2 Biotherapeutics Series B round October 2020: $71.5m
Industries
A2 Biotherapeutics is active in the following industries: